Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-12

Clinical Trial Update: Tumor-specific T Cells in Lung Cancer [NA]

View source ↗

Summary

A clinical trial update indicates a study evaluating tumor-specific T cells for non-small cell lung cancer is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tumor-specific T cells

Snippet

Sponsor: University Hospital Heidelberg | Conditions: Non-small Cell Lung Cancer | NA | Status: ACTIVE_NOT_RECRUITING